Market Research Logo

U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays

The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. Where chips were initially envisioned as carriers of microscopic binding sites for reactive molecules, today these chips are taking shape as miniature analyzers--smaller versions of analytical instrumentation. Newer chip technologies include microelectrophoresis and gas chromatography systems.

U.S. Markets in Analytical Chip Technology reports on the range of technologies currently available and in development, including DNA and protein chip technologies, tissue arrays, cellular arrays, reactive microchips, and more. In addition to the technologies and products in development, the report analyzes emerging applications and their market potential, including genomics, pharmacogenomics, drug discovery, proteomics, diagnostics, genetic family planning, prenatal testing, tissue-typing, agricultural and environmental applications, and food processing applications.

Extensive profiles of the industry’s top 20 participants, product reviews and R&D directions, as well as strategic planning and alliances are also included.


U.S. Market for Microarrays Could Top $5 Billion by 2010

New York, February 12, 2003 /PR Newswire — The rapidly expanding market for microarray technologies could surpass the $5 billion market by the end of the decade, according to a new study released today from Kalorama Information. Furthermore, some segments within the analytic chip market will experience growth in excess of 70% in the coming years.

The study, U.S. Markets in Analytical Chip Technology, predicts that advanced chip technologies will find broad applications across the spectrum of life sciences research and clinical practice in coming decades. However, it is microarray technologies and their use in drug discovery and development that represent the market opportunity in the immediate future.

"We decided to look at the analytical chip market from the perspective of market potential," notes Kenneth G. Krul, PhD, the author of the report. "The status of the current market in terms of revenues is misleading of the potential as a whole because there are so many research-oriented applications that are designed and used as ‘home-brew’ materials, and so many of the targets and projects are not associated with commonly available databases."

The study—which examines in turn DNA/gene, protein, cell, tissue, and microbiology microarrays—notes that the market will involve more than just the microarrays themselves. Proprietary targets on the arrays, proprietary surface technologies for the production of stable microarrays, proprietary custom microarray services, and microarray-based genome/proteome databases and informatics will all be part of the expanding field.

"If one were to believe the publicity surrounding the Human Genome Project, you’d think most of the work has already been done," comments Krul. "To the contrary, the field is just opening up and research opportunities appear virtually limitless at this time."

About Kalorama Information
Kalorama Information, an imprint of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or sheffner@kaloramainformation.com, or visit www.KaloramaInformation.com.

About MarketResearch.com
MarketResearch.com is the leading provider of global market intelligence products and services. With over 50,000 research publications from 350 research publishers, we offer instant online access to the world’s most extensive database of expert insights on global industries. Updated daily. For more information, contact Alison Williams at 301-468-3650 x203 or awilliams@marketresearch.com, or visit www.MarketResearch.com.

Chapter One: Executive Summary

    Scope and Methodology
    Size and Growth of Market

    • DNA/Gene Microarrays
    • Protein Microarrays
    • Microbiology Microarrays
    • Tissue Microarrays
    • Cell Microarrays

Chapter Two: Introduction

  • History and Development
  • Products

Chapter Three: DNA/Gene Microarrays

Background

DNA/Gene Microarray Production

DNA/Gene Microarray Applications

  • Genotyping
  • Gene Expression Measurement
  • DNA/Gene Microassay Informatics

DNA/Gene Microarray Commercialization

  • Accelr8 Technology
  • Affymetrix
  • Agilent Technologies
  • Beckman Coulter
  • BioDiscovery
  • BioRobotics
  • Cartesian Technologies
  • Clontech
  • Display Systems Biotech
  • Exiqon
  • GeneMachines
  • Genomic Solutions
  • GSI Lumonics
  • Illumina
  • Imaging Research
  • Incyte Pharmaceuticals
  • Mergen Ltd.
  • Microarrays, Inc.
  • Operon Technologies
  • OriGene Technologies
  • PerkinElmer Life Sciences/NEN Division
  • PerkinElmer Life Sciences/Packard Instrument Division
  • ProtoGene Laboratories
  • R&D Systems
  • Research Genetics
  • Rosetta Inpharmatics
  • Schleicher and Schuell
  • Sequenom
  • Sigma-Genosys
  • Stratagene
  • TeleChem International
  • Vysis

Chapter Four: Protein Microarrays

Background

Protein Array Technology

Protein Array Applications

  • Proteomics Solutions
  • Drug Discovery and Development
  • Clinical Diagnostics

Protein Microarray Commercialization

  • Advanced Array Technology
  • Aspira Biosystems, Inc.
  • Biacore AB
  • Biocept, Inc.
  • Ciphergen Biosystems, Inc.
  • Genicon Sciences Corporation
  • Genometrix
  • Hypromatrix, Inc.
  • MetriGenix, Inc.
  • Molecular Staging Inc.
  • Panomics, Inc.
  • PerkinElmer Life Sciences
  • PerkinElmer Life Sciences/Packard Bioscience
  • Prolinx, Inc.
  • Schleicher & Schuell BioSciences (S&S)
  • SomaLogic Inc.
  • Spinelix SA
  • TeleChem International

Chapter Five: Cell Microarrays

Background

Cell Microarray Technology

Microarray Applications

  • Drug Discovery and Development
  • Toxicology

Cell Microarray Commercialization

Chapter Six: Tissue Microarrays

    Background

    Tissue Microarray Technology

    Tissue Microarray Applications

    • Johns Hopkins University
    • Ontario Cancer Institute/Princess Margaret Hospital
    • University of Basel (Switzerland)
    • University of Michigan Medical School
    • Leeds Medical School (United Kingdom)

    Tissue Microarray Commercialization

    • Ambion
    • Ardais
    • BD Biosciences/Pharmingen
    • Beecher Instruments
    • BioCat
    • BioGenex
    • Clinomics
    • Gentaur
    • Invitrogen
    • Molecular Histology
    • Phargentech Ltd.
    • SuperBioChips Laboratories

Chapter Seven: Microbiology Microarrays

Background

Microbiology Array Technology

Microbiology Microarray Applications

  • Drug/Vaccine Discovery and Development
  • Pathogen Identification/Classification/Diagnosis

Microbiology Microarray Commercialization

  • Affymetrix
  • Ambion
  • Eurogenic
  • Nanogen
  • Qiagen
  • SigmaGenosys

Chapter Eight: Company Profiles

  • Accelr8 Technology Corporation
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Akceli, Inc.
  • Alpha Innotech Corporation
  • Ambion, Inc.
  • Beecher Instruments, Inc.
  • BioDiscovery
  • Bio-Rad Laboratories
  • Ciphergen Biosystems Inc.
  • Gene Machines
  • MicroSurfaces, Inc.
  • Molecular Histology, Inc.
  • MWG Biotech, Inc. USA
  • Nanogen, Inc.
  • Orchid Biosciences, Inc.
  • PerkinElmer Life Sciences
  • Research Genetics/Invitrogen Corporation
  • Scanalytics, Inc.
  • TeleChem International

Chapter Nine: Market Analysis

  • Overview
  • DNA/Gene Microarrays
  • Protein Microarrays
  • Cell Microarrays
  • Tissue Microarrays
  • Microbiology Microarrays

Chapter Ten: Conclusions and Strategic Implications

  • First Conclusion
  • Second Conclusion
  • Third Conclusion
  • Fourth Conclusion
  • Fifth Conclusion
  • Sixth Conclusion
  • Seventh Conclusion

Appendix A: Glossary

Appendix B: Company Directory

List of Exhibits

  • Figure 1-1: The Total Market for Analytical Microarrays in the United States 2000-2010
  • Table 1-1: Estimated Market Sizes for the Top Five Applications Segments for Analytic Chips in the United States 2000-2010
  • Figure 1-2: Growth in the U.S. Market for DNA/Gene Microarray Products
  • Figure 1-3: Growth in the U.S. Market for Protein Microarray Products
  • Figure 1-4: Growth in the U.S. Market for Microbiological Microarray Products
  • Figure 1-5: Growth in the U.S. Market for Tissue Microarray Products
  • Figure 1-6: Growth in the U.S. Market for Cell Microarray Products
  • Table 2-1: Key Analytical Microchip Systems and Related Products
  • Table 2-2: Key Analytical Microarray Services
  • Table 2-3: Key Analytical Microchip Reagent Products
  • Table 2-4: Key Analytical Microchip Control Reagent Products
  • Table 2-5: Key Analytical Microchip Nucleic Acid Modifying Products
  • Table 2-6: Key Analytical Microchip Probe Labeling and Hybridization Products
  • Table 2-7: Key Analytical Microchip RNA Amplification Products
  • Table 2-8: Key Analytical Microchip Microscopy Products
  • Table 2-9: Key Analytical Microchip Imaging System Products
  • Table 2-10: Key Analytical Microchip Microarray Production Equipment and Supplies
  • Table 2-11: Key Analytical Microchip Microarray Scanners and Accessories
  • Table 3-1: Selected Genomics Databases
  • Table 4-1: Key Participants in Protein Microarray Technology
  • Table 6-1: Key Tissue Microarray Products
  • Table 7-1: Applications of Microarray Technology to Microbiological Research
  • Table 7-2: Key Microbiological Microarray Products
  • Table 9-1: Historic and Projected U.S. Markets for Analytical Microarrays: 2000-2010
  • Figure 9-1: Trends in the Historic and Projected U.S. Markets for Analytical Microarrays: 2000-2010
  • Table 9-2: Principal Competitors in DNA/Gene Microarray Technology
  • Table 9-3: Historic and Projected U.S. Markets for DNA/Gene Microarrays: 2000-2010
  • Figure 9-2: Trends in the Historic and Projected U.S. Markets for DNA/Gene Microarrays 2000-2010
  • Table 9-4: Historic and Projected U.S. Markets for Protein Microarrays: 2000-2010
  • Figure 9-3: Trends in the Historic and Projected U.S. Markets for Protein Microarrays 2000-2010
  • Table 9-5: Key Participants in the U.S. Protein Microarray Products Markets
  • Table 9-6: Historic and Projected U.S. Markets for Cell Microarrays 2000-2010
  • Figure 9-4: Trends in the Historic and Projected U.S. Markets for Cell Microarrays 2000-2010
  • Table 9-7: Historic and Projected U.S. Markets for Tissue Microarrays 2000-2010
  • Figure 9-5: Trends in the Historic and Projected U.S. Markets for Tissue Microarrays: 2000-2010
  • Table 9-8: Key Participants in Tissue Microarray Manufacturing and Marketing
  • Table 9-9: Historic and Projected U.S. Markets for Microbiology Microarrays 2000-2010
  • Figure 9-6: Trends in the Historic and Projected U.S. Markets for Microbiology Microarrays 2000-2010

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report